Evidence map›Paper›PMID 31803733›Full record

ArticleFrontiers in bioengineering and biotechnology2019

Influence of Platelet Lysate on 2D and 3D Amniotic Mesenchymal Stem Cell Cultures.

Markus Pasztorek, Eva Rossmanith, Christoph Mayr, Fabian Hauser, Jaroslaw Jacak, Andreas Ebner, Viktoria Weber, Michael B Fischer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Frontiers in immunology · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Markus PasztorekDepartment for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
Eva RossmanithDepartment for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
Christoph MayrDepartment of Applied Experimental Biophysics, Institute of Biophysics, Johannes Kepler University Linz, Linz, Austria.
Fabian HauserSchool of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria.
Jaroslaw JacakSchool of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, Linz, Austria.
Andreas EbnerDepartment of Applied Experimental Biophysics, Institute of Biophysics, Johannes Kepler University Linz, Linz, Austria.
Viktoria WeberDepartment for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
Michael B FischerDepartment for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
Universität für Weiterbildung Krems · ATJohannes Kepler University of Linz · ATUniversity of Applied Sciences Upper Austria · AT

Funding

EPA EP-C-15-004
6 · The paper itself

Abstract

The mechanobiological behavior of mesenchymal stem cells (MSCs) in two- (2D) or three-dimensional (3D) cultures relies on the formation of actin filaments which occur as stress fibers and depends on mitochondrial dynamics involving vimentin intermediate filaments. Here we investigate whether human platelet lysate (HPL), that can potentially replace fetal bovine serum for clinical-scale expansion of functional cells, can modulate the stress fiber formation, alter mitochondrial morphology, change membrane elasticity and modulate immune regulatory molecules IDO and GARP in amnion derived MSCs. We can provide evidence that culture supplementation with HPL led to a reduction of stress fiber formation in 2D cultured MSCs compared to a conventional growth medium (MSCGM). 3D MSC cultures, in contrast, showed decreased actin concentrations independent of HPL supplementation. When stress fibers were further segregated by their binding to focal adhesions, a reduction in ventral stress fibers was observed in response to HPL in 2D cultured MSCs, while the length of the individual ventral stress fibers increased. Dorsal stress fibers or transverse arcs were not affected. Interestingly, ventral stress fiber formation did not correlate with membrane elasticity. 2D cultured MSCs did not show differences in the Young's modulus when propagated in the presence of HPL and further cultivation to passage 3 also had no effect on membrane elasticity. In addition, HPL reduced the mitochondrial mass of 2D cultured MSCs while the mitochondrial mass in 3D cultured MSCs was low initially. When mitochondria were segregated into punctuate, rods and networks, a cultivation-induced increase in punctuate and network mitochondria was observed in 2D cultured MSCs of passage 3. Finally, mRNA and protein expression of the immunomodulatory molecule IDO relied on stimulation of 2D culture MSCs with pro-inflammatory cytokines IFN-γ and TNF-α with no effect upon HPL supplementation. GARP mRNA and surface expression was constitutively expressed and did not respond to HPL supplementation or stimulation with IFN-γ and TNF-α. In conclusion, we can say that MSCs cultivated in 2D and 3D are sensitive to medium supplementation with HPL with changes in actin filament formation, mitochondrial dynamics and membrane elasticity that can have an impact on the immunomodulatory function of MSCs.

Indexed as

membrane elasticitymesenchymal stem cellsmitochondrial dynamicsplatelet lysatestress fibers

Identifiers

PMID31803733
PMCPMC6873824
OpenAlexW2983401826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.